Walkers assists Norton Rose Fulbright on sale of contract research organisation (CRO) HeaDS to Veeda

HeaDS is a full-service Global Contract Research Organization (CRO) dedicated to the conduct of clinical studies, with particular expertise in hemato-oncology studies. They provide the complete range of clinical trial services, from start-up to completion, from Phase I to IV. They also provide strategic oncology drug development consulting and expert advice

A multi-disciplinary Irish Walkers' team assisted Norton Rose Fulbright, who acted as lead counsel to the sellers of Heads on its sale to Veeda.

Partner Eoin Ryan led on the corporate side and was assisted by Noreen Smyth (Corporate), Jonathan Sheehan, Padhraic Mulpeter and Eire Dempsey (Tax), William Greensmyth and Keith Hyland (Insolvency and Dispute Resolution), Paddy Rath (Finance), Shane Martin (Regulatory), Rachel Rodgers (Real Estate), and Susan Battye and Jennifer Bassett (Employment).

Of the transaction, Eoin said: “This is another example of the ability of the Walkers' team to work on and assist with high-value cross-border M&A transactions. We were delighted in this instance to assist both the Norton Rose Athens and London teams in completing this transaction and wish the sellers the very best in their future endeavours."